Concepedia

Mary K. Wloch

MK

Statistics

Publications

19

Citations

1.1K

H-Index

15

Active since

1989

Affiliations

Vical (United States)(Current)

Duke University Hospital

Duke Medical Center

University of California San Diego

Duke University

Mary K. Wloch is an author at Vical (United States) specializing in immunology, life sciences, and vaccinology.

Publications per year

1989–2013

19

Publications

19

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

Mohamed A. Kharfan‐Dabaja, Michael Boeckh, Marissa B. Wilck et al. · The Lancet Infectious Diseases · 2012 · 230 citations · Full text

, , +16

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

Larry Smith, Mary K. Wloch, Ming Ye et al. · Vaccine · 2010 · 141 citations

, , +17

Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects

Mary K. Wloch, Larry Smith, Souphaphone Boutsaboualoy et al. · The Journal of Infectious Diseases · 2008 · 140 citations · Full text

, , +17

Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens

Jukka Hartikka, Vesselina Bozoukova, Marilyn E. Ferrari et al. · Vaccine · 2001 · 97 citations

, , +11

A DNA-Based Vaccine for the Prevention of Human Cytomegalovirus-Associated Diseases

Cheryl Selinsky, Catherine J. Luke, Mary K. Wloch et al. · Human Vaccines · 2005 · 75 citations

, , +17

1–5 of 19